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Abstract  
AIM: To report a potential association of thrombosis, thrombocytopenia with iron deficiency anaemia.  
CASE REPORT: A 43-year-old female experienced an episode of a headache, with bilateral papilledema by 
neurological examination, magnetic resonance venography (MRV) brain showed cerebrovenous thrombosis 
(CVT), iron deficiency anaemia and thrombocytopenia by blood investigations, that was treated with iron 
supplementations and anticoagulation.  
CONCLUSION: In this patient, cerebrovenous thrombosis (CVT) was discovered in a patient with 
thrombocytopenia and iron deficiency anaemia and treated with iron supplements and anticoagulation, we 
concluded that thrombocytopenia is not a protective factor against thrombosis especially with iron deficiency 
anaemia. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Cerebral venous thrombosis (CVT) presents 
acutely to the emergency department usually with 
signs and symptoms of raised intracranial tension, 
namely headache, vomiting and blurred vision, altered 
sensorium, seizures and focal deficits and if the 
patient is not treated in time can result in permanent 
deficits, coma and even death [1]. However 
sometimes cerebral venous thrombosis can manifest 
in an indolent fashion as seen in our patient whose 
only complaint was a persistent headache. 
 
 
Case Report 
 
A 43-year-old female presented with the 
intermittent bitemporal headache of a throbbing nature 
mild to moderate in intensity associated with nausea, 
vomiting, and blurring of vision of 1-month duration, 
which was not responding to analgesics. She was 
diabetic, hypertensive dyslipidemic and obese. She 
also complained of menorrhagia of 3 years duration. 
On admission, she was afebrile, and her vitals were 
normal. Neurological examination revealed bilateral 
papilledema, no evidence of meningism or any focal 
neurological deficit. Routine blood investigation 
showed microcytic hypochromic anemia with 
hemoglobin value of 7.5 g/L (normal range: 12 - 16), 
RBC’s value of 4.56 (normal range: 4.2 - 5.4), MCV is 
55.6 (normal range: 82 - 97), low platelet count of 
63,000/cumm (normal range 140,000-440,000), serum 
iron concentrate 3.3 mcmol/L (normal range: 9 - 30), 
transferrin 3.2 g/L (normal range: 2 - 3.6), iron 
saturation 4% (normal range: 20 - 40%), heptaglobin 
is 2.26 g/L (normal range: 0.30 - 2). Coagulation 
profile was normal including antithrombin III, factor V 
(laden), and activated protein C resistance, 
antiphospholipid antibodies, fibrinogen, protein C, 
protein S, and homocysteine. Serum vitamin B12 and 
folate were normal. Screening for vasculitis including 
rheumatoid factor, lupus anticoagulant, and Protein 
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immunofixation electrophoresis was all normal. Upper 
gastrointestinal and lower digestive endoscopies, 
endovaginal sonography, thoracoabdominal and 
pelvic computed tomography were performed and did 
not detect any malignant disease or source of active 
bleeding. MRI brain and MR venography revealed 
right transverse and sigmoid sinus, Right internal 
jugular vein thrombosis (Fig. 1). A lumbar puncture 
study showed the high opening pressure of 34 cm 
H2O with no cells, normal glucose and protein. 
 
Figure 1: A) Normal MRI brain Axial FLAIR; B) MRV showing 
absent flow in the right transverse, sigmoid, and right internal 
jugular vein suggestive of cerebral venous thrombosis 
 
The patient was treated as per protocol with 
low molecular weight (LMW) heparin, and this was 
later switched to Tablet Warfarin. Since she was 
found to be anaemic oral iron supplementation was 
also started. Daily haemogram was monitored, and it 
was observed that the platelet count rapidly increased 
and corrected to 200,000/cumm within one week. The 
patient’s headache and blurring of vision gradually 
improved. The patient was discharged with gradual 
improvement of haemoglobin value of 8.2 g/dL, and 
the platelet count rose to 336,000/cumm. The cause 
of anaemia was presumed to be the prolonged history 
of menorrhagia this patient had after ruling out all 
other causes of the anaemia. 
 
 
Discussion 
 
Iron deficiency anaemia usually manifests as 
fatigue, exertional dyspnea and malaise. Neurological 
manifestations are not so common [2]. Our patient 
presented with symptoms of raised intracranial 
tension and who on the investigation was found to 
have CVT. Iron deficiency anaemia (IDA) is rarely 
recognized as a significant risk factor for stroke [3]. 
There are case reports of the association of iron 
deficiency and cerebral venous thrombosis with 
pseudotumor cerebri presentation which has been 
more often reported in children but only a few reports 
in the adult population [4 - 8]. Also, our patient had 
thrombocytopaenia which one would have expected to 
cause a bleeding tendency but paradoxically could 
have contributed to the development of the venous 
thrombosis as explained below. 
Some mechanisms have been proposed to 
explain the association between Iron deficiency 
anaemia and thrombosis. Firstly iron is considered to 
be a regulator of thrombopoiesis, and normal iron 
levels are required to prevent thrombocytosis by 
inhibiting thrombopoiesis and consequent 
hypercoagulable state [9]. It was postulated that iron 
either directly or indirectly inhibits the rise in platelets 
above steady state by inhibitory mechanisms; but also 
is required for the production or synthesis of one or 
more essential platelet components. By this, they 
postulated that when an iron deficiency occurs, it 
affects the inhibitory compartment first, and 
thrombopoiesis is stimulated leading to 
thrombocytosis; but if the iron depletion is more 
severe, the essential component is affected leading to 
thrombocytopenia. However, the level of iron 
deficiency at which the switch occurs is yet to be 
established [10]. 
Another mechanism by which iron deficiency 
may contribute to a hypercoagulable state is by 
affecting flow patterns within the vessels [11]. The 
microcytosis resulting from iron deficiency causes 
reduced red cell deformability and increased viscosity, 
which contributes to thrombosis in a negative–
pressure environment, as is found in veins. Akin et al. 
have suggested that the decrease in antioxidant 
defence in iron deficiency anaemia may cause 
increased oxidative stress which in return may result 
in a tendency toward platelet aggregation [12]. Thus 
the abnormal platelet count and function observed in 
iron deficiency anaemia could act synergistically to 
promote thrombus formation especially in the setting 
of an underlying atherosclerotic disease, all these 
conditions lead to a turbulent blood flow, causing 
platelets to come more frequently in contact with 
endothelial lining [11]. 
Unlike children, in which the major cause of 
IDA is insufficient dietary iron intake, chronic blood 
loss is the most common cause of IDA in adults 
especially in women with menstrual irregularities as 
was seen in our patient who suffered from 
menorrhagia. The resolution of severe symptomatic 
anaemia along with thrombocytopenia following iron 
supplementation strengthens the hypothesis that iron 
therapy plays an important role in improving 
thrombocytopenia associated with IDA [13]. 
The association of menorrhagia, IDA, and 
thrombocytopenia that was noticed in our patient was 
also rarely reported in the literature, and the resolution 
of thrombocytopenia with iron supplements will occur 
provided other causes of thrombocytopenia are 
excluded such as acute hemorrhage, hemolysis, 
trauma, folate and vitamin B12 deficiency and 
idiopathic thrombocytopenic purpura [13]. Akoi et al. 
evaluated the effects of iron therapy on platelet 
function among women with menorrhagia. They found 
 Kamel et al. Cerebral venous thrombosis in a patient with iron deficiency anemia and thrombocytopenia: A case report 
______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Dec 15; 5(7):967-969.                                                                                                                                                         969 
 
 
iron deficiency anaemia in women caused arachidonic 
acid-induced platelet dysfunction causing increased 
menstrual blood loss which can be reversed through 
iron repletion [14]. In a study conducted by Jens et al. 
to identify venous thromboembolism risk factors in 
patients with thrombocytopenia, (platelet count <100 
x10⁹/L) it was concluded that the risk of venous 
thrombosis in patients with thrombocytopenia was the 
same as in patients with normal platelet counts [15]. 
Therefore it can be inferred that low platelet count 
does not give any protection against 
thromboembolism. Similarly, it has also been 
observed that certain subpopulations of patients with 
Idiopathic thrombocytopenic purpura (ITP) are at 
significantly higher risk of thrombotic complications 
[16-17]. 
In conclusion, this case report illustrates that 
CVT can occur in the setting of anaemia and 
thrombocytopenia. Correction of iron deficiency 
rapidly restored the platelet count and reversal of the 
hypercoagulable state which may have contributed to 
the rapid recovery of the patient albeit in the presence 
of adequate anticoagulation. Hence this case 
illustrates that iron deficiency anaemia and 
thrombocytopenia can be considered as independent 
risk factors for CVT. Whether the menorrhagia is an 
additional risk factor for a hypercoagulable state is 
open to debate and needs to be studied.  
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